119 related articles for article (PubMed ID: 15962390)
1. Relationship between the downregulation of HLA class I antigen and clinicopathological significance in gastric cancer.
Shen YQ; Zhang JQ; Miao FQ; Zhang JM; Jiang Q; Chen H; Shan XN; Xie W
World J Gastroenterol; 2005 Jun; 11(23):3628-31. PubMed ID: 15962390
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer.
Wang XC; Zhang JQ; Shen YQ; Miao FQ; Xie W
J Exp Clin Cancer Res; 2006 Mar; 25(1):115-9. PubMed ID: 16761627
[TBL] [Abstract][Full Text] [Related]
3. MHC class I and II antigens on gastric carcinomas and autologous mucosa.
Ferron A; Perez-Ayala M; Concha A; Cabrera T; Redondo M; Oliva MR; Ruiz-Cabello F; Garrido F
J Immunogenet; 1989; 16(4-5):413-23. PubMed ID: 2639912
[TBL] [Abstract][Full Text] [Related]
4. Gastric cancer progression may involve a shift in HLA-E profile from an intact heterodimer to β2-microglobulin-free monomer.
Sasaki T; Ravindranath MH; Terasaki PI; Freitas MC; Kawakita S; Jucaud V
Int J Cancer; 2014 Apr; 134(7):1558-70. PubMed ID: 24105714
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen (HLA)-E and HLA-F expression in gastric cancer.
Ishigami S; Arigami T; Okumura H; Uchikado Y; Kita Y; Kurahara H; Maemura K; Kijima Y; Ishihara Y; Sasaki K; Uenosono Y; Natsugoe S
Anticancer Res; 2015 Apr; 35(4):2279-85. PubMed ID: 25862890
[TBL] [Abstract][Full Text] [Related]
6. Expression of HLA class I and class II in gastric carcinoma in relation to pathologic stage.
Klein B; Klein T; Nyska A; Shapira J; Figer A; Schwartz A; Rakovsky E; Livni E; Lurie H
Tumour Biol; 1991; 12(2):68-74. PubMed ID: 2028181
[TBL] [Abstract][Full Text] [Related]
7. Lesion HLA-F expression is irrelevant to prognosis for patients with gastric cancer.
Zhang JG; Zhang X; Lin A; Yan WH
Hum Immunol; 2013 Jul; 74(7):828-32. PubMed ID: 23542057
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between the expression of human leukocyte antigen-b in peripheral blood leukocytes and the differentiation and metastasis of gastric carcinoma].
Zhang Y; Zou X; Yang XJ; Li XL; Zhao SM; Gao YJ
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):49-52. PubMed ID: 17575694
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of locus-specific human lymphocyte antigen class I expression in Epstein-Barr virus-associated gastric cancer: implication for viral-induced immune evasion.
Dutta N; Gupta A; Mazumder DN; Banerjee S
Cancer; 2006 Apr; 106(8):1685-93. PubMed ID: 16541432
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of HLA class I expressing in gastric carcinoma defined by monoclonal anti-pan HLA class I antibody, EMR8-5.
Lee HW; Min SK; Ju YS; Sung J; Lim MS; Yang DH; Lee BH
J Gastrointest Surg; 2011 Aug; 15(8):1336-43. PubMed ID: 21512844
[TBL] [Abstract][Full Text] [Related]
11. Clinical-pathological implication of human leukocyte antigen-F-positive gastric adenocarcinoma.
Ishigami S; Arigami T; Setoyama T; Okumura H; Sasaki K; Uchikado Y; Kurahara H; Kijima Y; Nishizono Y; Nakajo A; Natsugoe S
J Surg Res; 2013 Oct; 184(2):802-6. PubMed ID: 23706560
[TBL] [Abstract][Full Text] [Related]
12. [Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in laryngeal squamous cell carcinoma].
Zeng Q; Wang XL; Xu ZG; Lü N; Zheng S; Zhao QZ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):234-40. PubMed ID: 22805026
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of HLA class I heavy chain expression in patients with gastric cancer.
Ueda Y; Ishikawa K; Shiraishi N; Yokoyama S; Kitano S
J Surg Oncol; 2008 Apr; 97(5):451-5. PubMed ID: 18247377
[TBL] [Abstract][Full Text] [Related]
14. Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer.
Ishigami S; Arigami T; Uenosono Y; Matsumoto M; Okumura H; Uchikado Y; Kita Y; Nishizono Y; Maemura K; Kijima Y; Nakajo A; Owaki T; Ueno S; Hokita S; Natsugoe S
Cancer Immunol Immunother; 2012 Oct; 61(10):1663-9. PubMed ID: 22374482
[TBL] [Abstract][Full Text] [Related]
15. HLA-class I expression in gastric cancer.
Ishigami S; Natsugoe S; Nakajo A; Arigami T; Kitazono M; Okumura H; Matsumoto M; Uchikado Y; Setoyama T; Sasaki K; Aikou T
J Surg Oncol; 2008 Jun; 97(7):605-8. PubMed ID: 18459158
[TBL] [Abstract][Full Text] [Related]
16. The relationship between KRAS gene mutations and HLA class I antigen downregulation in the metastasis of non-small cell lung cancer.
He XP; Song FJ; Liu XY; Wang Z; Li XX; Liu FY; Chen G; Jiang WP
J Int Med Res; 2013 Oct; 41(5):1473-83. PubMed ID: 23975858
[TBL] [Abstract][Full Text] [Related]
17. HLA antigens are candidate markers for prediction of lymph node metastasis in gastric cancer.
Ogoshi K; Tajima T; Mitomi T; Tsuji K
Clin Exp Metastasis; 1996 May; 14(3):277-81. PubMed ID: 8674282
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
19. Analysis of human lymphocyte antigen class I expression in gastric cancer by reverse transcriptase-polymerase chain reaction.
Dutta N; Majumder D; Gupta A; Mazumder DN; Banerjee S
Hum Immunol; 2005 Feb; 66(2):164-9. PubMed ID: 15695002
[TBL] [Abstract][Full Text] [Related]
20. Association of MHC class I expression and lymph node metastasis of gastric carcinoma.
Yoshii M; Tanaka H; Ohira M; Muguruma K; Sakurai K; Kubo N; Yashiro M; Sawada T; Hirakawa K
Hepatogastroenterology; 2013 May; 60(123):611-5. PubMed ID: 23108078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
